A D2C challenger brand has just been told to pull its attack ads. The Delhi High Court has restrained Kwick Living, the company behind eco home care brand Beco, from running its “War on What’s Hidden” campaign aimed at Hindustan Unilever’s Surf Excel and Vim.
For every insurgent brand that grows by calling out the category leader, this interim order is a clear signal: a claim can be technically true and still land you in court.
The Key Facts
- Parties: Hindustan Unilever (HUL) vs Kwick Living (Beco)
- Campaign: “War on What’s Hidden”, naming two ingredients (LAS and BIT) in HUL products
- Implied message: HUL products could trigger skin irritation, itching or eczema, so consumers should switch to Beco
- HUL’s allegations: Disparagement, trademark and trade dress infringement, copyright infringement, passing off and unfair competition
- Beco’s defence: The ingredients are genuinely present, backed by scientific and regulatory material
- Court direction: Remove and recall the objectionable ads across all formats within one week
- Status: Interim order only; the full dispute is still to be decided at trial
What the Court Actually Said
- Criticising rivals is allowed: Showing a competitor unfavourably is not illegal on its own
- The overall message decides: Ads are judged as a whole, through the eyes of an average consumer
- True parts can build a false whole: Individually accurate lines can still add up to a misleading impression
- Numbers create perceived risk: Chemical names, concentrations and percentages suggested a definite danger to buyers
- Context counts: Pairing “switch now” calls with Beco’s “hypoallergenic”, “baby safe” and “pet safe” claims shaped the ruling
- Science deferred: Competing lab reports were left for expert evidence at trial
Why This Matters for Performance Marketers
Challenger brands love “us vs them” creatives because they convert. Ingredient callouts, side by side comparisons and “what your current brand hides” hooks routinely beat soft brand messaging on Meta and YouTube.
- Ad sets are now legal documents: Every hook, overlay and caption contributes to the “overall message”
- Scale multiplies exposure: Dozens of creative variants mean dozens of potential objectionable claims
- Recall costs are real: Pulling ads across every format in a week means lost learnings, wasted spend and reset algorithms
- Brand trust takes a hit: A public injunction can undo the credibility the campaign was built to earn
The Engage Positive View: Win on Your Strengths, Not Their Weaknesses
Comparative advertising still works. But the safest high performing creatives lead with what your product does, not what a named rival might do to the customer.
Red flags to check before launching comparative ads:
- Naming or showing a rival brand or packaging: Raises trademark and trade dress exposure instantly
- Health or safety implications: Skin, allergy, child or pet safety angles face the strictest scrutiny
- Scientific terms without context: Chemical names and percentages can imply risk you cannot prove
- “Switch now” framing next to fear claims: Strengthens the reading of disparagement
- Unsubstantiated superlatives: “Safe”, “hypoallergenic” and “toxin free” need solid, documented backing
A Safer Comparative Ad Checklist for D2C Brands
- Read the ad as a whole: Review the full creative the way a regular shopper would, not line by line
- Keep substantiation on file: Test reports, certifications and sources for every claim before launch
- Prefer category comparisons: “Most conventional detergents” carries less risk than naming a specific brand
- Lead with your proof: Showcase your formulation, certifications and results rather than a rival’s risks
- Add a legal review gate: Build compliance sign off into your creative approval workflow, especially for ASCI sensitive categories
- Audit live variants regularly: Dynamic creatives and UGC ads can drift into risky claims over time
The Bottom Line
The Beco case does not end comparative advertising in India. It raises the bar. Brands that pair bold creative with rigorous substantiation will keep winning share, while those relying on implied fear risk losing both the campaign and the momentum.
